On July 12, 2019 the board of directors of Calmare Therapeutics Incorporation elected Dr. Santanu Das to fill the vacancy on the Board created by Carl O'Connell's resignation. On July 12, 2019, Dr. Das was elected to the executive committee of the Board. On July 12, 2019, the Board established an executive committee (the "Committee") of the Board consisting of Peter Brennan, Rustin Howard, Conrad Mir and Santanu Das.